ProShares MSCI EAFE Dividend Growers ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy

64

EFAD
ProShares MSCI EAFE Dividend Growers ETF

Last Price:

$42.39

Seasonality Move:

1.64%

Buy

63

GPCR
Structure Therapeutics, Inc.

Last Price:

$71.39

Seasonality Move:

-34.19%

Buy

64

ProShares MSCI EAFE Dividend Growers ETF (EFAD) is a Buy

Is ProShares MSCI EAFE Dividend Growers ETF a Buy, Sell or Hold?

The current ProShares MSCI EAFE Dividend Growers ETF [EFAD] share price is $42.10. The Score for EFAD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
EFAD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

63

Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EFAD Stock Price Chart

What is ProShares MSCI EAFE Dividend Growers ETF's stock price today?

The ProShares MSCI EAFE Dividend Growers ETF share price today is $42.10

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EFAD is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

The Structure Therapeutics, Inc. share price today is $71.29

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

EFAD Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.05	Buy
Relative Strength Index (14 RSI):	53.04	Buy
Chaikin Money Flow:	2511	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(41.36 - 42.2)	Buy
Bollinger Bands (100):	(41.64 - 42.56)	Sell

GPCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	8.5	Buy
Relative Strength Index (14 RSI):	72.85	Buy
Chaikin Money Flow:	1903413	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(33.41 - 65.27)	Buy
Bollinger Bands (100):	(17 - 45.24)	Buy

EFAD Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	42.02	Buy
20-day SMA:	41.95	Buy
50-day SMA:	41.94	Buy
200-day SMA:	41.58	Buy
8-day EMA:	42.01	Buy
20-day EMA:	41.95	Buy
50-day EMA:	41.96	Buy
200-day EMA:	41.45	Buy

GPCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	64.43	Buy
20-day SMA:	52.92	Buy
50-day SMA:	40.28	Buy
200-day SMA:	26.09	Buy
8-day EMA:	64	Buy
20-day EMA:	55.88	Buy
50-day EMA:	44.22	Buy
200-day EMA:	31.26	Buy

ProShares MSCI EAFE Dividend Growers ETF Earnings Growth & EFAD Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

ProShares MSCI EAFE Dividend Growers ETF Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22
	Dec
	09	10	11	12	15	16	17	18	19	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 23
	Dec
	10	11	12	15	16	17	18	19	22	23
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):